Patent · US Expired

Apparatus and method for improved photoplethysmographic monitoring of multiple hemoglobin species using emitters having optimized center wavelengths

US5983122A · kind A · utility

175Cited by
3References
24Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 12, 1997
Grant dateNov 9, 1999
Priority date
Expiry dateDec 12, 2017

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61B5/14552
  • WIPO fieldMedical technology
  • WIPO sectorInstruments

Abstract

An improved method and apparatus for the photoplethysmographic monitoring of blood analyte parameters, specifically oxyhemoglobin, deoxyhemoglobin (reduced hemoglobin), carboxyhemoglobin and, in addition, in a four emitter apparatus, methemoglobin, uses a plurality of beams of light having different spectral contents to trans-illuminate the tissue of a patient. The apparatus and method require the application of an emitter set comprised of four emitters. The emitters may be LED's or laser diodes. In the three analyte system the center wavelength of the emitters must fall within three specific bands. In the four emitter system (capable of measuring methemoglobin) the center wavelength of the emitters in the emitter set must fall within four predetermined bands and the emitters having the two lowest center wavelengths must be at least 5 nanometers apart. The apparatus can use emitters which are located either in a probe, or, preferably, in the monitor, as well as a photodiode which can either be located in the patient probe or in the monitor.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.